POCN's Multiple Myeloma Center of Excellence - Multiple Myeloma: A POCN Center of Excellence

Multiple Myeloma Resources
Chosen by Advanced
Practice Providers

Clinical guidelines
Patient support and education resources
Research updates

Daratumumab: Durable Efficacy in Heavily Treated Multiple Myeloma

Daratumumab monotherapy demonstrated promising efficacy and a manageable safety profile in heavily pretreated patients with multiple myeloma in a pooled, post-hoc analysis of the GEN501 and SIRIUS studies....

CURATED BY: Jill N. Burke,
CNP, DipACLM

Jill N. Burke,

CNP, DipACLM
Nurse Practitioner, Massachusetts General Hospital

Study Reveals Need for Better Therapies in Triple-Class Exposed Multiple Myeloma

The LocoMMotion study, a multinational prospective observational trial, examined the effectiveness and safety of real-world clinical practice treatments in triple-class exposed patients with multiple myeloma who had received proteasome inhibitors,...

CURATED BY:
Laura J. Zitella,
MS, RN, ACNP-BC, AOCN

Multiple Myeloma Advances Call for Standardized IgG-RT to Tackle Immune Challenges

Recent advancements in multiple myeloma (MM) therapies have extended survival but introduced immunosuppressive challenges, including hypogammaglobulinemia, which increases infection risk. T-cell engaging therapies have improved outcomes for heavily pretreated patients,...

CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Accurate Diagnostic Model for Newly Diagnosed Multiple Myeloma

Researchers of a recent study aimed to identify clinical laboratory parameters for diagnosing newly diagnosed multiple myeloma (NDMM) and develop a diagnostic model for early and precise detection....

CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Physician Associate and Nurse Practitioner Contributors to the Multiple Myeloma Center of Excellence

POCN’s Multiple Myeloma Center of Excellence is curated by practicing clinical physician associates and nurse practitioners who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.

Donna D. Catamero,

ANP-BC, OCN, CCRC
Associate Director, Myeloma Research, Icahn School of Medicine at Mount Sinai

Laura J. Zitella,

MS, RN, ACNP-BC, AOCN
Nurse Practitioner, Associate Clinical Professor, University of California San Francisco

Jill N. Burke,

CNP, DipACLM
Nurse Practitioner, Massachusetts General Hospital

Danielle Roberts,

MS, MMSc, PA-C
Associate Chief of Education, Winship Cancer Institute of Emory University

Provided by an unrestricted grant from

Company
Contact

Partner with Us
Ambassador Program

Daratumumab: Durable Efficacy in Heavily Treated Multiple Myeloma

Jill N. Burke,

Study Reveals Need for Better Therapies in Triple-Class Exposed Multiple Myeloma

Multiple Myeloma Advances Call for Standardized IgG-RT to Tackle Immune Challenges

Accurate Diagnostic Model for Newly Diagnosed Multiple Myeloma

Physician Associate and Nurse Practitioner Contributors to the Multiple Myeloma Center of Excellence

Provided by an unrestricted grant from

© 2024 Point of Care Network, LLC. All Rights Reserved.

© 2024 Point of Care Network, LLC. All Rights Reserved.

Share